Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer

British Journal of Radiology

Volumn 82, Issue 980, 2009, Pages 632-639

  Sohaib, S A ^a   Cook, G ^a   Allen, S D ^a   Hughes, M ^a   Eisen, T ^a   Gore, M ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEDRONATE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; INTERMETHOD COMPARISON; KIDNEY CANCER; LUNG METASTASIS; MALE; PROSPECTIVE STUDY; SKELETON; SOFT TISSUE METASTASIS; SPINE METASTASIS; WHOLE BODY MRI;

ADULT; AGED; BONE NEOPLASMS; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M MEDRONATE; WHOLE BODY IMAGING;

EID: 67650686791     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/52773262     Document Type: Article

References (22)

1. Cancer statistics. Cancer Research UK; 2007. Available from: http://info.cancerresearchuk.org/cancerstats [Accessed 8 June 2009].
2. Griffin N, Gore ME, Sohaib SA. Imaging in metastatic renal cell carcinoma. AJR Am J Roentgenol 2007;189:360-370 (Pubitemid 47195921)
3. Blacher E, Johnson DE, Haynie TP. Value of routine radionuclide bone scans in renal cell carcinoma. Urology 1985;26:432-434 (Pubitemid 17045568)
4. Seaman E, Goluboff ET, Ross S, Sawczuk IS. Association of radionuclide bone scan and serum alkaline phosphatase in patients with metastatic renal cell carcinoma. Urology 1996;48:692-695 (Pubitemid 26398686)
5. Althausen P, Althausen A, Jennings LC, Mankin HJ. Prognostic factors and surgical treatment of osseous metastases secondary to renal cell carcinoma. Cancer 1997;80:1103-1109 (Pubitemid 27427610)
6. Adiga GU, Dutcher JP, Larkin M, Garl S, Koo J. Characterization of bone metastases in patients with renal cell cancer. BJU Int 2004;93:1237-1240 (Pubitemid 38823944)
7. Johnston C, Brennan S, Ford S, Eustace S. Whole body MR imaging: applications in oncology. Eur J Surg Oncol 2006;32:239-246
8. Eustace S, Tello R, DeCarvalho V, Carey J, Wroblicka JT, Melhem ER, Yucel EK. A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol 1997;169:1655-1661 (Pubitemid 127469800)
9. Steinborn MM, Heuck AF, Tiling R, Bruegel M, Gauger L, Reiser MF. Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system. J Comput Assist Tomogr 1999;23:123-129 (Pubitemid 29095482)
10. Lauenstein TC, Freudenberg LS, Goehde SC, Ruehm SG, Goyen M, Bosk S, Debatin JF, Barkhausen J. Whole-body MRI using a rolling table platform for the detection of bone metastases. Eur Radiol 2002;12:2091-2099 (Pubitemid 36940299)
11. Engelhard K, Hollenbach HP, Wohlfart K, von Imhoff E, Fellner FA. Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer. Eur Radiol 2004;14:99-105. (Pubitemid 38181060)
12. Ghanem N, Altehoefer C, Kelly T, Lohrmann C, Winterer J, Schafer O et al. Whole-body MRI in comparison to skeletal scintigraphy in detection of skeletal metastases in patients with solid tumors. In Vivo 2006;20:173-182 (Pubitemid 43103737)
13. Frat A, Agildere M, Gencoglu A, Cakir B, Akin O, Akcali Z, Aktas A. Value of whole-body turbo short tau inversion recovery magnetic resonance imaging with panoramic table for detecting bone metastases: comparison with 99MTc-methylene diphosphonate scintigraphy. J Comput Assist Tomogr 2006;30:151-156 (Pubitemid 43052317)
14. Larkin JM, Chowdhury S, Gore ME. Drug insight: advances in renal cell carcinoma and the role of targeted therapies. Nat Clin Pract Oncol 2007;4:470-479 (Pubitemid 47393803)
15. O'Connell MJ, Hargaden G, Powell T, Eustace SJ. Wholebody turbo short tau inversion recovery MR imaging using a moving tabletop. AJR Am J Roentgenol 2002;179:866-868
16. Ghanem N, Uhl M, Brink I, Schafer O, Kelly T, Moser E, Langer M. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET-CT for the detection of metastases of bone. Eur J Radiol 2005;55:41-55. (Pubitemid 40798487)
17. Groves AM, Beadsmoore CJ, Cheow HK, Balan KK, Courtney HM, Kaptoge S, et al. Can 16-detector multislice CT exclude skeletal lesions during tumour staging? Implications for the cancer patient. Eur Radiol 2006;16:1066-1073
18. Schmidt GP, Reiser MF, Baur-Melnyk A. Whole-body imaging of the musculoskeletal system: the value of MR imaging. Skeletal Radiol 2007;36:1109-1119 (Pubitemid 350112367)
19. Buhmann Kirchhoff S, Becker C, Duerr HR, Reiser M, Baur-Melnyk A. Detection of osseous metastases of the spine: comparison of high resolution multi-detector-CT with MRI. Eur J Radiol 2009;69:567-573
20. Wu HC, Yen RF, Shen YY, Kao CH, Lin CC, Lee CC. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients with renal cell carcinomas - a preliminary report. J Cancer Res Clin Oncol 2002;128:503-506
21. Schmidt GP, Schoenberg SO, Schmid R, Stahl R, Tiling R, Becker CR, et al. Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PETCT. Eur Radiol 2007;17:939-949 (Pubitemid 46766875)
22. Koga S, Tsuda S, Nishikido M, Ogawa Y, Hayashi K, Hayashi T, Kanetake H. The diagnostic value of bone scan in patients with renal cell carcinoma. J Urol 2001;166: 2126-2128 (Pubitemid 33065235)